Dafna Capital Management LLC Theseus Pharmaceuticals, Inc. Transaction History

Dafna Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$5.21 - $14.05 $256,154 - $690,782	49,166 Added 60.06%	131,025 $1.16 Million
Q4 2022 Feb 14, 2023	SELL	$4.69 - $8.36 $187 - $334	-40 Reduced 0.05%	81,859 $407,000
Q2 2022 Aug 15, 2022	BUY	$5.04 - $14.05 $8,946 - $24,938	1,775 Added 2.22%	81,899 $453,000
Q1 2022 May 16, 2022	SELL	$8.75 - $14.51 $152,040 - $252,125	-17,376 Reduced 17.82%	80,124 $924,000
Q4 2021 Feb 14, 2022	BUY	$8.98 - $20.09 $875,550 - $1.96 Million	97,500 New	97,500 $1.24 Million

1.06M

Ticker THRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,713,400
Description
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.